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Background
Washington, DC (DC) has one of the highest HIV/AIDS
rates in the U.S and cancer is the second leading cause
of death among DC residents. This study sought to
examine the demographic characteristics and survival of
persons with AIDS defining cancers (ADCs) compared
to those with non-AIDS defining cancers (NADCs)
between the early HAART era (1996-2001) and the late
HAART era (2002-2006) in DC.
Methods
Cases reported from 1996-2006 to the DC Cancer Registry
and the AIDS Surveillance Registry were linked using a
probabilistic matching algorithm. Cases were included if
the cancer occurred from 4 months to 60 months post-
AIDS diagnosis and were stratified into ADCs and
NADCs for analyses. Cancer diagnoses were stratified into
the early and late HAART eras to compare the availability
of HAART on the distribution of cancer type. Kaplan-
Meier survival analysis and adjusted Cox proportional
hazards regression were used to assess survival time and
risk of death by cancer type.
Results
From 1996-2006, among 8,800 AIDS cases, 300 (3.4%)
cases had a cancer diagnosis. NADCs accounted for 51%
of cancers and were significantly more likely to be diag-
nosed with AIDS (p<0.0001) and cancer (p<0.0001) at
40 years or older and had a significantly longer median
time from AIDS to cancer diagnosis (2.46 vs. 1.75 years,
p = 0 . 0 1 )c o m p a r e dt oA D C s .T h em o s tc o m m o nA D C s
were Kaposi sarcoma (40%) and non-Hodgkin lym-
phoma (NHL) (44%); the most common NADC cases
were lung (20%), Hodgkin lymphoma (8%) and anal
(8%) cancer. ADCs accounted for 56% of cancer cases in
the late-HAART as compared to the early-HAART per-
iod (45%). Mortality within the first year of cancer diag-
nosis was similar (ADC 41% vs. NADC 37%) and no
statistical difference in survival time was observed. In
the adjusted model, NHL and lung cases were signifi-
cantly more likely to die as compared to other cancers
(NHL HR=3.06; Lung HR=3.44).
Conclusions
In DC, despite high HIV/AIDS and cancer prevalence,
only a small proportion of AIDS cases also develop cancer
with ADCs and NADCs being equally common. HAART
availability does not seem to have altered survival among
ADCs and NADCs. Survival among NHL cases was rela-
tively low reflecting the need for increased access to care
among HIV+ persons. NADC cases are most likely devel-
oping cancers related to advancing age with higher pro-
portions of lung cancers being observed. Public health
efforts should focus on lung cancer prevention and contin-
ued monitoring of HIV-infected persons for cancers.
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